[Translation] A Phase I clinical trial to investigate the safety, tolerability and pharmacokinetics of TR128 in patients with advanced solid tumors
评估TR128胶囊单药口服给药在晚期实体瘤患者中的安全性和耐受性,确定剂量限制性毒性(DLT)、最大耐受剂量(MTD)和II期临床试验推荐剂量(RP2D)
[Translation] To evaluate the safety and tolerability of TR128 capsules as a single oral agent in patients with advanced solid tumors, and to determine the dose-limiting toxicity (DLT), maximum tolerated dose (MTD), and recommended dose for Phase II clinical trials (RP2D)